-
Kratom (Mitragyna speciosa): worldwide issues
Current Opinion in Psychiatry - Current Issue jul 1, 2020 | 07:00
Read more...
Purpose of reviewTo inform readers about the increasingly popular Western dietary supplement, kratom (Mitragyna speciosa) and how the products are available in the Western world compared with traditional Southeast Asian use. Kratom has been traditionally used for increasing stamina of[…] -
New psychoactive substances in Taiwan: challenges and strategies
Current Opinion in Psychiatry - Current Issue jul 1, 2020 | 07:00
Read more...
Purpose of reviewAbuse of new psychoactive substances (NPS) has been a new global concern. So far, there has been no international consensus on legislative control of NPS. Scrutiny of Taiwan's illegal drug use history reveals that legislation and policy play[…] -
Drug checking to detect fentanyl and new psychoactive substances
Current Opinion in Psychiatry - Current Issue jul 1, 2020 | 07:00
Read more...
Purpose of reviewDrug checking services invite drug consumers to anonymously submit drug samples for chemical analysis and provide feedback of results. Drugs are tested for strength/dose and/or presence of adulterants. Drug checking appears to be more common in recent years[…] -
Global strategy for New Psychoactive Substances: an update
Current Opinion in Psychiatry - Current Issue jul 1, 2020 | 07:00
Read more...
Purpose of reviewThe aim of this review is to provide an update on recent trends of New Psychoactive Substances (NPS) and the current global strategies implemented to manage them.Recent findingsThe number of NPS has increased from 166 in 2009 to[…] -
Editorial introductions
Current Opinion in Psychiatry - Current Issue jul 1, 2020 | 07:00
Read more...
No abstract available -
Advice for Clinicians on How to Treat Comorbid Anxiety and Depression
JAMA Psychiatry Current Issue jun 1, 2020 | 02:00This article offers advice to clinicians on approaches to treating comorbid anxiety and depression.
Read more... -
Effect Size and Blinding in Lumateperone Trial
JAMA Psychiatry Current Issue jun 1, 2020 | 02:00To the Editor The article “Efficacy and Safety of Lumateperone for Treatment of Schizophrenia: A Randomized Clinical Trial” by Correll and colleagues was notable for its thorough data analyses (including multiple sensitivity analyses of the primary outcome) and for the[…]
Read more... -
Effect Size and Blinding in Lumateperone Trial —Reply
JAMA Psychiatry Current Issue jun 1, 2020 | 02:00In Reply We thank Gouse et al for raising 2 points regarding the efficacy and safety of lumateperone. The effect size of −0.30 for lumateperone, 42 mg, on the Positive and Negative Syndrome Scale total score is in the range[…]
Read more... -
Update to Open Access Status
JAMA Psychiatry Current Issue jun 1, 2020 | 02:00In the Original Investigation titled “Association of Magnetoencephalographically Measured High-Frequency Oscillations in Visual Cortex With Circuit Dysfunctions in Local and Large-scale Networks During Emerging Psychosis,” published online March 25, 2020, the authors updated the status of the article so that[…]
Read more... -
JAMA Psychiatry
JAMA Psychiatry Current Issue jun 1, 2020 | 02:00Mission Statement: JAMA Psychiatry strives to publish original, state-of-the-art studies and commentaries of general interest to clinicians, scholars, and research scientists in psychiatry, mental health, behavioral science, and allied fields. The journal seeks to inform and to educate its readers[…]
Read more...
-
Inicio
-
De interés
- Últimos artículos de revistas científicas
